• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将形式与功能相联系:人工抗原呈递细胞设计的生物物理方面。

Linking form to function: Biophysical aspects of artificial antigen presenting cell design.

作者信息

Perica Karlo, Kosmides Alyssa K, Schneck Jonathan P

机构信息

Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, MD, USA; Institute of Cell Engineering, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Institute of Cell Engineering, Johns Hopkins School of Medicine, Baltimore, MD, USA; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, USA; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA; Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.

出版信息

Biochim Biophys Acta. 2015 Apr;1853(4):781-90. doi: 10.1016/j.bbamcr.2014.09.001. Epub 2014 Sep 6.

DOI:10.1016/j.bbamcr.2014.09.001
PMID:25200637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4344884/
Abstract

Artificial antigen presenting cells (aAPCs) are engineered platforms for T cell activation and expansion, synthesized by coupling T cell activating proteins to the surface of cell lines or biocompatible particles. They can serve both as model systems to study the basic aspects of T cell signaling and translationally as novel approaches for either active or adoptive immunotherapy. Historically, these reductionist systems have not been designed to mimic the temporally and spatially complex interactions observed during endogenous T cell-APC contact, which include receptor organization at both micro- and nanoscales and dynamic changes in cell and membrane morphologies. Here, we review how particle size and shape, as well as heterogenous distribution of T cell activating proteins on the particle surface, are critical aspects of aAPC design. In doing so, we demonstrate how insights derived from endogenous T cell activation can be applied to optimize aAPC, and in turn how aAPC platforms can be used to better understand endogenous T cell stimulation. This article is part of a Special Issue entitled: Nanoscale membrane organisation and signalling.

摘要

人工抗原呈递细胞(aAPC)是用于T细胞激活和扩增的工程平台,通过将T细胞激活蛋白偶联到细胞系表面或生物相容性颗粒上合成。它们既可以作为研究T细胞信号传导基本方面的模型系统,也可以作为主动或过继性免疫疗法的新方法用于转化研究。从历史上看,这些简化系统并非设计用于模拟内源性T细胞与抗原呈递细胞(APC)接触过程中观察到的时空复杂相互作用,这些相互作用包括微观和纳米尺度上的受体组织以及细胞和膜形态的动态变化。在此,我们综述了颗粒大小和形状,以及T细胞激活蛋白在颗粒表面的异质分布,是aAPC设计的关键方面。在此过程中,我们展示了如何将源自内源性T细胞激活的见解应用于优化aAPC,以及反过来aAPC平台如何用于更好地理解内源性T细胞刺激。本文是名为:纳米级膜组织与信号传导的特刊的一部分。

相似文献

1
Linking form to function: Biophysical aspects of artificial antigen presenting cell design.将形式与功能相联系:人工抗原呈递细胞设计的生物物理方面。
Biochim Biophys Acta. 2015 Apr;1853(4):781-90. doi: 10.1016/j.bbamcr.2014.09.001. Epub 2014 Sep 6.
2
Nanoscale artificial antigen presenting cells for cancer immunotherapy.用于癌症免疫治疗的纳米级人工抗原呈递细胞。
Mol Immunol. 2018 Jun;98:13-18. doi: 10.1016/j.molimm.2018.02.016. Epub 2018 Mar 7.
3
Nanoscale artificial antigen presenting cells for T cell immunotherapy.用于 T 细胞免疫治疗的纳米级人工抗原呈递细胞。
Nanomedicine. 2014 Jan;10(1):119-29. doi: 10.1016/j.nano.2013.06.015. Epub 2013 Jul 24.
4
Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat Melanoma.可生物降解的阳离子聚合物共混物用于制备增强的人工抗原呈递细胞以治疗黑色素瘤。
ACS Appl Mater Interfaces. 2021 Feb 24;13(7):7913-7923. doi: 10.1021/acsami.0c19955. Epub 2021 Feb 12.
5
Particle-Based Artificial Antigen-Presenting Cell Systems for T Cell Activation in Adoptive T Cell Therapy.基于粒子的人工抗原呈递细胞系统在过继性 T 细胞治疗中用于 T 细胞的激活。
ACS Nano. 2024 Mar 26;18(12):8571-8599. doi: 10.1021/acsnano.3c10180. Epub 2024 Mar 14.
6
Surface-Engineering of Red Blood Cells as Artificial Antigen Presenting Cells Promising for Cancer Immunotherapy.红细胞表面工程作为人工抗原呈递细胞在癌症免疫治疗中的应用前景。
Small. 2017 Oct;13(40). doi: 10.1002/smll.201701864. Epub 2017 Sep 1.
7
Biologically Inspired Design of Nanoparticle Artificial Antigen-Presenting Cells for Immunomodulation.基于生物学原理设计的纳米颗粒人工抗原呈递细胞用于免疫调节。
Nano Lett. 2017 Nov 8;17(11):7045-7054. doi: 10.1021/acs.nanolett.7b03734. Epub 2017 Oct 10.
8
Nanoengineering approaches to the design of artificial antigen-presenting cells.纳米工程方法设计人工抗原呈递细胞。
Nanomedicine (Lond). 2013 Jul;8(7):1173-89. doi: 10.2217/nnm.13.98.
9
Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy.形状很重要:用于癌症免疫治疗的可生物降解各向异性纳米颗粒人工抗原呈递细胞。
Acta Biomater. 2023 Apr 1;160:187-197. doi: 10.1016/j.actbio.2023.02.023. Epub 2023 Feb 21.
10
A novel system of artificial antigen-presenting cells efficiently stimulates Flu peptide-specific cytotoxic T cells in vitro.一种新型的人工抗原呈递细胞系统可有效地在体外刺激 Flu 肽特异性细胞毒性 T 细胞。
Biochem Biophys Res Commun. 2011 Aug 5;411(3):530-5. doi: 10.1016/j.bbrc.2011.06.164. Epub 2011 Jul 2.

引用本文的文献

1
enhancement of CD8+ T cell activity using functionalized hydrogel encapsulating tonsil-derived lymphatic endothelial cells.使用包裹扁桃体来源的淋巴管内皮细胞的功能化水凝胶增强CD8 + T细胞活性。
Theranostics. 2025 Jan 1;15(3):850-874. doi: 10.7150/thno.100079. eCollection 2025.
2
Cell surface morphology mimicking nano-bio platform for immune cell stimulation.用于免疫细胞刺激的模拟细胞表面形态的纳米生物平台。
iScience. 2024 Sep 26;27(11):111033. doi: 10.1016/j.isci.2024.111033. eCollection 2024 Nov 15.
3
Immunomodulatory nanoparticles activate cytotoxic T cells for enhancement of the effect of cancer immunotherapy.

本文引用的文献

1
Magnetic field-induced T cell receptor clustering by nanoparticles enhances T cell activation and stimulates antitumor activity.纳米颗粒介导的磁场诱导T细胞受体聚集可增强T细胞活化并刺激抗肿瘤活性。
ACS Nano. 2014 Mar 25;8(3):2252-60. doi: 10.1021/nn405520d. Epub 2014 Feb 24.
2
CD28 and CD3 have complementary roles in T-cell traction forces.CD28 和 CD3 在 T 细胞牵引力中具有互补作用。
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2241-6. doi: 10.1073/pnas.1315606111. Epub 2014 Jan 27.
3
Cross talk between CD3 and CD28 is spatially modulated by protein lateral mobility.
免疫调节纳米颗粒激活细胞毒性 T 细胞,增强癌症免疫疗法的效果。
Nanoscale. 2024 Oct 3;16(38):17699-17722. doi: 10.1039/d4nr01780c.
4
Ganglioside-Functionalized Nanoparticles for Chimeric Antigen Receptor T-Cell Activation at the Immunological Synapse.神经节苷脂功能化纳米颗粒用于免疫突触处嵌合抗原受体 T 细胞的激活。
ACS Nano. 2022 Nov 22;16(11):18408-18420. doi: 10.1021/acsnano.2c06516. Epub 2022 Oct 25.
5
Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation.人工抗原呈递细胞拓扑结构决定 T 细胞激活。
ACS Nano. 2022 Sep 27;16(9):15072-15085. doi: 10.1021/acsnano.2c06211. Epub 2022 Aug 15.
6
Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells.基于肽-HLA 的免疫治疗平台,用于直接调节抗原特异性 T 细胞。
Sci Rep. 2021 Sep 28;11(1):19220. doi: 10.1038/s41598-021-98716-z.
7
Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance.细菌外膜囊泡作为疫苗研究和对抗抗菌药物耐药性的多功能工具。
mBio. 2021 Aug 31;12(4):e0170721. doi: 10.1128/mBio.01707-21. Epub 2021 Aug 10.
8
Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic.工程化红细胞作为现成的异体抗肿瘤治疗剂。
Nat Commun. 2021 May 11;12(1):2637. doi: 10.1038/s41467-021-22898-3.
9
Semiflexible Immunobrushes Induce Enhanced T Cell Activation and Expansion.半柔性免疫刷诱导增强的T细胞活化和扩增。
ACS Appl Mater Interfaces. 2021 Apr 14;13(14):16007-16018. doi: 10.1021/acsami.0c21994. Epub 2021 Apr 2.
10
Augmentation of T-Cell Activation by Oscillatory Forces and Engineered Antigen-Presenting Cells.振荡力和工程抗原呈递细胞增强 T 细胞激活。
Nano Lett. 2019 Oct 9;19(10):6945-6954. doi: 10.1021/acs.nanolett.9b02252. Epub 2019 Sep 3.
CD3 和 CD28 之间的串扰受蛋白质侧向流动性的空间调节。
Mol Cell Biol. 2014 Mar;34(6):955-64. doi: 10.1128/MCB.00842-13. Epub 2013 Dec 30.
4
Cognate peptide-MHC complexes are expressed as tightly apposed nanoclusters in virus-infected cells to allow TCR crosslinking.同源肽-MHC 复合物在病毒感染的细胞中作为紧密相邻的纳米簇表达,以允许 TCR 交联。
J Immunol. 2014 Jan 1;192(1):52-8. doi: 10.4049/jimmunol.1301224. Epub 2013 Dec 4.
5
Nanoscale ligand spacing influences receptor triggering in T cells and NK cells.纳米级配体间距影响T细胞和自然杀伤细胞中的受体触发。
Nano Lett. 2013;13(11):5608-14. doi: 10.1021/nl403252x. Epub 2013 Oct 21.
6
Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells.人工抗原呈递细胞对 CD8+T 细胞激活的颗粒形状依赖性。
Biomaterials. 2014 Jan;35(1):269-277. doi: 10.1016/j.biomaterials.2013.09.050. Epub 2013 Oct 5.
7
Selective activation of antigen-experienced T cells by anti-CD3 constrained on nanoparticles.纳米颗粒上的抗 CD3 对抗原经验 T 细胞的选择性激活。
J Immunol. 2013 Nov 15;191(10):5107-14. doi: 10.4049/jimmunol.1301433. Epub 2013 Oct 4.
8
Nanoscale artificial antigen presenting cells for T cell immunotherapy.用于 T 细胞免疫治疗的纳米级人工抗原呈递细胞。
Nanomedicine. 2014 Jan;10(1):119-29. doi: 10.1016/j.nano.2013.06.015. Epub 2013 Jul 24.
9
Nanoengineering approaches to the design of artificial antigen-presenting cells.纳米工程方法设计人工抗原呈递细胞。
Nanomedicine (Lond). 2013 Jul;8(7):1173-89. doi: 10.2217/nnm.13.98.
10
An HLA-modified ovarian cancer cell line induced CTL responses specific to an epitope derived from claudin-1 presented by HLA-A*24:02 molecules.一种 HLA 修饰的卵巢癌细胞系诱导针对由 HLA-A*24:02 分子呈递的 Claudin-1 衍生表位的 CTL 反应。
Hum Immunol. 2013 Sep;74(9):1103-10. doi: 10.1016/j.humimm.2013.06.030. Epub 2013 Jun 24.